MedTrace Logo

Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation

NCT05717855 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2023-02-08

No results posted yet for this study

Summary

Evaluation of prenatal optic chiasm (OC) is important for the differential diagnosis of septo-optic dysplasia (SOD), which is a congenital optic disc anomaly, and the absence of the cavum septum pellucidum (CSP). Septo-optic dysplasia is associated with a wide range of neurological abnormalities, including hypoplasia of the visual pathways, CSP agenesis, and developmental delay.

Conditions

  • 2D Ultrasound
  • Cavum Septum Pellucidum
  • Septooptic Dysplasia
  • Optic Chiasma
  • Willis Polygon

Interventions

DIAGNOSTIC_TEST

Displaying optic chiasm for screening septooptic dysplasia

Displaying and measuring the width and length of the optic chiasm for screening septooptic dysplasia with ultrasound between 16-20 weeks of gestation

Sponsors & Collaborators

  • Gaziosmanpasa Research and Education Hospital

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-21
Primary Completion
2021-03-21
Completion
2021-04-21

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05717855 on ClinicalTrials.gov